Just some questions for more experienced investors.
1. The composition of the top shareholders has changed dramatically over 12 months from a mix of funds to a basket case of institutional investors presumably even more so after the cap raise so it's extremely loose held.
2. Logically, if the results or preliminary non-market findings were good you'd see fewer institutionals on board (I.e. a couple investors taking on more risk).
3. I still don't really understand why they would do a capital raise before results given that assay results are only weeks away.
Cheers
Just some questions for more experienced investors.1. The...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.80M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $30.16K | 7.387M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 85 | 49580103 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 17688676 | 19 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| RDN (ASX) Chart |